Cargando…
Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year Survival
BACKGROUND/METHODS: This study determines the co-expression of mammaglobin-A, vascular endothelial growth factor receptor-3 (VEGFR3) and Ki67 by immunohistochemistry (IHC) in tissue samples from 80 patients undergoing breast surgery (cancer or benign disease). The tissue expression was compared with...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595648/ https://www.ncbi.nlm.nih.gov/pubmed/31263371 http://dx.doi.org/10.1177/1178223419858957 |
_version_ | 1783430436891918336 |
---|---|
author | Baker, Elizabeth Whiteoak, Naomi Hall, Louise France, James Wilson, Deborah Bhaskar, Pudupalayam |
author_facet | Baker, Elizabeth Whiteoak, Naomi Hall, Louise France, James Wilson, Deborah Bhaskar, Pudupalayam |
author_sort | Baker, Elizabeth |
collection | PubMed |
description | BACKGROUND/METHODS: This study determines the co-expression of mammaglobin-A, vascular endothelial growth factor receptor-3 (VEGFR3) and Ki67 by immunohistochemistry (IHC) in tissue samples from 80 patients undergoing breast surgery (cancer or benign disease). The tissue expression was compared with the tumour histopathology and Kaplan Meier 5-year survival analysis was performed. RESULTS: Positive breast tissue expression was observed in 53% samples for mammaglobin, 41% Ki67 and 65% VEGFR3 with a significant positive correlation between Ki67 and VEGFR3 co-expression. Ki67 and VEGFR3 expression correlated with the breast tumour grade and Ki67 expression also correlated with oestrogen receptor (ER) status. At 5 years post-operatively, 6/80 patients had died and 3 patients were alive but had cancer recurrence. High Ki67 expression significantly correlated with poor survival (disease-free and overall). CONCLUSIONS: In this study, VEGFR3 and Ki67 expression but not mammaglobin-A correlated with breast tumour pathology. Positive Ki67 expression was also associated with a poor 5-year survival outcome. |
format | Online Article Text |
id | pubmed-6595648 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-65956482019-07-01 Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year Survival Baker, Elizabeth Whiteoak, Naomi Hall, Louise France, James Wilson, Deborah Bhaskar, Pudupalayam Breast Cancer (Auckl) Original Research BACKGROUND/METHODS: This study determines the co-expression of mammaglobin-A, vascular endothelial growth factor receptor-3 (VEGFR3) and Ki67 by immunohistochemistry (IHC) in tissue samples from 80 patients undergoing breast surgery (cancer or benign disease). The tissue expression was compared with the tumour histopathology and Kaplan Meier 5-year survival analysis was performed. RESULTS: Positive breast tissue expression was observed in 53% samples for mammaglobin, 41% Ki67 and 65% VEGFR3 with a significant positive correlation between Ki67 and VEGFR3 co-expression. Ki67 and VEGFR3 expression correlated with the breast tumour grade and Ki67 expression also correlated with oestrogen receptor (ER) status. At 5 years post-operatively, 6/80 patients had died and 3 patients were alive but had cancer recurrence. High Ki67 expression significantly correlated with poor survival (disease-free and overall). CONCLUSIONS: In this study, VEGFR3 and Ki67 expression but not mammaglobin-A correlated with breast tumour pathology. Positive Ki67 expression was also associated with a poor 5-year survival outcome. SAGE Publications 2019-06-26 /pmc/articles/PMC6595648/ /pubmed/31263371 http://dx.doi.org/10.1177/1178223419858957 Text en © The Author(s) 2019 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Baker, Elizabeth Whiteoak, Naomi Hall, Louise France, James Wilson, Deborah Bhaskar, Pudupalayam Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year Survival |
title | Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year Survival |
title_full | Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year Survival |
title_fullStr | Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year Survival |
title_full_unstemmed | Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year Survival |
title_short | Mammaglobin-A, VEGFR3, and Ki67 in Human Breast Cancer Pathology and Five Year Survival |
title_sort | mammaglobin-a, vegfr3, and ki67 in human breast cancer pathology and five year survival |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595648/ https://www.ncbi.nlm.nih.gov/pubmed/31263371 http://dx.doi.org/10.1177/1178223419858957 |
work_keys_str_mv | AT bakerelizabeth mammaglobinavegfr3andki67inhumanbreastcancerpathologyandfiveyearsurvival AT whiteoaknaomi mammaglobinavegfr3andki67inhumanbreastcancerpathologyandfiveyearsurvival AT halllouise mammaglobinavegfr3andki67inhumanbreastcancerpathologyandfiveyearsurvival AT francejames mammaglobinavegfr3andki67inhumanbreastcancerpathologyandfiveyearsurvival AT wilsondeborah mammaglobinavegfr3andki67inhumanbreastcancerpathologyandfiveyearsurvival AT bhaskarpudupalayam mammaglobinavegfr3andki67inhumanbreastcancerpathologyandfiveyearsurvival |